Minimally invasive treatment of chronic iliofemoral venous occlusive disease

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Volumn 1, Issue 2, 2013, Pages 146-153

  De Wolf, Mark Antonius Friedrich ^a,b   Arnoldussen, B Carsten Willem ^a   Grommes, Jochen ^c   Hsien, Shu Gi ^a   Nelemans, A Patricia Joan ^a   De Haan, Michiel Willem ^a   De Graaf, Rick ^a   Wittens, Cees Hendrikus ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; GADOFOSVESET; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON;

ADULT; AGED; ANGIOPLASTY; ARTERIOVENOUS FISTULA; BALLOON CATHETER; BLOOD CLOT LYSIS; CLAUDICATION; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; ECHOGRAPHY; ENDOPHLEBECTOMY; FEASIBILITY STUDY; FEMALE; FEMORAL VEIN; FOLLOW UP; GUIDE WIRE; HUMAN; ILIOFEMORAL VEIN OCCLUSION; INFERIOR CAVA VEIN; LOWER EXTREMITY DEEP VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PHLEBOGRAPHY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECANALIZATION; RETROSPECTIVE STUDY; SAFETY; SINGLE DRUG DOSE; STENT; TREATMENT FAILURE; VASCULAR PATENCY; VASCULAR SURGERY; VEIN OCCLUSION;

EID: 84881285379     PISSN: 2213333X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvsv.2012.07.002     Document Type: Conference Paper

References (30)

1. Meissner MH, Moneta G, Burnand K, et al. The hemodynamics and diagnosis of venous disease. J Vasc Surg 2007;46(Suppl S):4S-24S.
2. Bulger CM, Jacobs C, Patel NH. Epidemiology of acute deep vein thrombosis. Tech Vasc Interv Radiol 2004;7:50-4.
3. Wentel TD, Neumann HA. Management of the postthrombotic syndrome: the Rotterdam approach. Semin Thromb Hemost 2006;32: 814-21.
4. Kahn SR. The post thrombotic syndrome. Thromb Res 2011;127 (Suppl 3):S89-92.
5. Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of healthrelated quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008;6:1105-12.
6. Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1994;31:49-53.
7. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002;162:1144-8.
8. MacDougall DA, Feliu AL, Boccuzzi SJ, Lin J. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm 2006;63(20 Suppl 6):S5-15.
9. Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 1997;126:454-7.
10. Arnoldussen CW, Wittens CH. An imaging approach to deep vein thrombosis and the lower extremity thrombosis classification. Phlebology 2012;27(Suppl 1):143-8.
11. de Wolf MA, Wittens CH, Kahn SR. Incidence and risk factors of the post-thrombotic syndrome. Phlebology 2012;27(Suppl 1):85-94.
12. Franzeck UK, Schalch I, Jager KA, Schneider E, Grimm J, Bollinger A. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zurich study). Circulation 1996;93:74-9.
13. Haenen JH, Janssen MC, van Langen H, et al. The postthrombotic syndrome in relation to venous hemodynamics, as measured by means of duplex scanning and strain-gauge plethysmography. J Vasc Surg 1999;29:1071-6.
14. Holmstrom M, Aberg W, Lockner D, Paul C. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis. Thromb Haemost 1999;82:1222-6.
15. O'Donnell TF Jr, Browse NL, Burnand KG, Thomas ML. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977;22:483-8.
16. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
17. Prandoni P, Villalta S, Bagatella P, et al. The clinical course of deepvein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997;82:423-8.
18. Kibbe MR, Ujiki M, Goodwin AL, Eskandari M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg 2004;39:937-43.
19. Raju S, Neglen P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg 2006;44:136-43; discussion: 144.
20. van der Laan L, Vos JA, de Boer E, van den Berg JC, Moll FL. [The central-venous compression syndrome: rare, but adequately treatable with endovascular stenting]. Ned Tijdschr Geneeskd 2004;148:433-7.
21. Kearon C KS, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2006;133(6 Suppl):454S-545S.
22. Akesson H, Brudin L, Dahlstrom JA, Eklof B, Ohlin P, Plate G. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 1990;4:43-8.
23. Neglen P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg 2007;46:979-90.
24. Raju S, Hollis K, Neglen P. Use of compression stockings in chronic venous disease: patient compliance and efficacy. Ann Vasc Surg 2007;21:790-5.
25. Ye K, Lu X, Li W, et al. Long-term outcomes of stent placement for symptomatic nonthrombotic iliac vein compression lesions in chronic venous disease. J Vasc Interv Radiol 2012;23:497-502.
26. Gutzeit A, Zollikofer Ch L, Dettling-Pizzolato M, Graf N, Largiader J, Binkert CA. Endovascular stent treatment for symptomatic benign iliofemoral venous occlusive disease: long-term results 1987-2009. Cardiovasc Intervent Radiol 2011;34:542-9.
27. Hartung O, Loundou AD, Barthelemy P, Arnoux D, Boufi M, Alimi YS. Endovascular management of chronic disabling ilio-caval obstructive lesions: long-term results. Eur J Vasc Endovasc Surg 2009;38:118-24.
28. Titus JM, Moise MA, Bena J, Lyden SP, Clair DG. Iliofemoral stenting for venous occlusive disease. J Vasc Surg 2011 Mar;53:706-12.
29. Arnoldussen CW, Toonder I, Wittens CH. A novel scoring system for lower-extremity venous pathology analysed using magnetic resonance venography and duplex ultrasound. Phlebology 2012;27(Suppl 1): 163-70.
30. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-52.